Literature DB >> 25268936

The role of IgG hypersensitivity in the pathogenesis and therapy of depressive disorders.

Hanna Karakuła-Juchnowicz1, Patrycja Szachta2, Aneta Opolska3, Justyna Morylowska-Topolska1, Mirosława Gałęcka2, Dariusz Juchnowicz4, Paweł Krukow1, Zofia Lasik2.   

Abstract

Depressive episodes are associated not only with changes in neurotransmission in the central nervous system, but also may lead to structural changes in the brain through neuroendocrine, inflammatory, and immunological mechanisms. The aim of this article is to present a new hypothesis connecting the inflammatory theory of depression with IgG food hypersensitivity and leaky gut syndrome. This new potential pathway that may mediate the pathogenesis of depression implies the existence of subsequent developmental stages. Overproduction of zonulin triggered, for example, by gliadin through activation of the epidermal growth factor receptor and protease-activated receptor causes loosening of the tight junction barrier and an increase in permeability of the gut wall ('leaky gut'). This results in a process allowing larger molecules that would normally stay in the gut to cross into the bloodstream and in the induction of IgG-dependent food sensitivity. This condition causes an increased immune response and consequently induces the release of proinflammatory cytokines, which in turn may lead to the development of depressive symptoms. It seems advisable to assess the intestinal permeability using as a marker, for example, zonulin and specific IgG concentrations against selected nutritional components in patients with depression. In the case of increased IgG concentrations, the implementation of an elimination-rotation diet may prove to be an effective method of reducing inflammation. This new paradigm in the pathogenesis of depressive disorders linking leaky gut, IgG-dependent food sensitivity, inflammation, and depression is promising, but still needs further studies to confirm this theory.

Entities:  

Keywords:  Depression; Gluten sensitivity; IgG hypersensitivity; Inflammatory theory of depression; Leaky gut; Zonulin

Mesh:

Substances:

Year:  2016        PMID: 25268936     DOI: 10.1179/1476830514Y.0000000158

Source DB:  PubMed          Journal:  Nutr Neurosci        ISSN: 1028-415X            Impact factor:   4.994


  5 in total

1.  Mood Disorders and Gluten: It's Not All in Your Mind! A Systematic Review with Meta-Analysis.

Authors:  Eleanor Busby; Justine Bold; Lindsey Fellows; Kamran Rostami
Journal:  Nutrients       Date:  2018-11-08       Impact factor: 5.717

2.  The study evaluating the effect of probiotic supplementation on the mental status, inflammation, and intestinal barrier in major depressive disorder patients using gluten-free or gluten-containing diet (SANGUT study): a 12-week, randomized, double-blind, and placebo-controlled clinical study protocol.

Authors:  Hanna Karakula-Juchnowicz; Joanna Rog; Dariusz Juchnowicz; Igor Łoniewski; Karolina Skonieczna-Żydecka; Paweł Krukow; Malgorzata Futyma-Jedrzejewska; Mariusz Kaczmarczyk
Journal:  Nutr J       Date:  2019-08-31       Impact factor: 3.271

3.  Associations between food-specific IgG and health outcomes in an asymptomatic physical examination cohort.

Authors:  Mingxia Wu; Xiaofang Wang; Li Sun; Zongtao Chen
Journal:  Nutr Metab (Lond)       Date:  2022-03-19       Impact factor: 4.169

4.  The Food-Specific Serum IgG Reactivity in Major Depressive Disorder Patients, Irritable Bowel Syndrome Patients and Healthy Controls.

Authors:  Hanna Karakula-Juchnowicz; Mirosława Gałęcka; Joanna Rog; Anna Bartnicka; Zuzanna Łukaszewicz; Pawel Krukow; Justyna Morylowska-Topolska; Karolina Skonieczna-Zydecka; Tomasz Krajka; Kamil Jonak; Dariusz Juchnowicz
Journal:  Nutrients       Date:  2018-04-28       Impact factor: 5.717

5.  Leaky gut biomarkers in depression and suicidal behavior.

Authors:  L Ohlsson; A Gustafsson; E Lavant; K Suneson; L Brundin; Å Westrin; L Ljunggren; D Lindqvist
Journal:  Acta Psychiatr Scand       Date:  2018-11-01       Impact factor: 6.392

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.